BRIZZI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.525
EU - Europa 5.451
AS - Asia 2.695
SA - Sud America 448
AF - Africa 127
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.261
Nazione #
US - Stati Uniti d'America 5.420
GB - Regno Unito 1.210
IT - Italia 1.207
RU - Federazione Russa 958
CN - Cina 858
SG - Singapore 799
IE - Irlanda 620
BR - Brasile 367
SE - Svezia 301
FR - Francia 288
DE - Germania 276
VN - Vietnam 251
UA - Ucraina 238
HK - Hong Kong 221
FI - Finlandia 147
KR - Corea 147
IN - India 99
BD - Bangladesh 96
ZA - Sudafrica 61
TR - Turchia 49
CA - Canada 46
MX - Messico 39
JP - Giappone 35
NL - Olanda 34
PL - Polonia 33
ES - Italia 30
AR - Argentina 28
NG - Nigeria 18
PK - Pakistan 17
AT - Austria 16
BE - Belgio 16
IQ - Iraq 16
ID - Indonesia 15
EC - Ecuador 14
AU - Australia 13
TW - Taiwan 12
CI - Costa d'Avorio 10
AE - Emirati Arabi Uniti 8
CL - Cile 8
CZ - Repubblica Ceca 8
PT - Portogallo 8
VE - Venezuela 8
GR - Grecia 7
KE - Kenya 7
LT - Lituania 7
MY - Malesia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CH - Svizzera 6
CO - Colombia 6
EE - Estonia 6
IL - Israele 6
JO - Giordania 6
SN - Senegal 6
AM - Armenia 5
AZ - Azerbaigian 5
DZ - Algeria 5
EG - Egitto 5
IR - Iran 5
PY - Paraguay 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
LV - Lettonia 4
MA - Marocco 4
PE - Perù 4
AL - Albania 3
CM - Camerun 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
JM - Giamaica 3
LK - Sri Lanka 3
NP - Nepal 3
RS - Serbia 3
SR - Suriname 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
SV - El Salvador 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
Totale 14.250
Città #
Southend 1.081
Dallas 727
Dublin 618
Fairfield 498
Singapore 450
Ashburn 365
Siena 309
Santa Clara 276
Moscow 266
Menlo Park 252
Beijing 251
Chandler 251
San Jose 247
Woodbridge 231
Hong Kong 206
Wilmington 196
Jacksonville 185
Hefei 169
Seattle 166
Houston 161
Cambridge 143
Seoul 141
Ann Arbor 138
Milan 131
Los Angeles 108
Princeton 108
Florence 95
Helsinki 86
The Dalles 79
Nanjing 78
Ho Chi Minh City 76
New York 73
Lauterbourg 69
Council Bluffs 66
Hanoi 65
Johannesburg 58
Fremont 53
Rome 52
Boardman 42
Munich 42
San Mateo 38
São Paulo 34
Bengaluru 30
Dearborn 30
Frankfurt am Main 27
London 27
San Diego 27
Tokyo 27
Buffalo 25
Izmir 25
Shanghai 25
Nanchang 21
Naples 21
Orem 21
Chicago 20
Redondo Beach 20
Düsseldorf 19
Shenyang 19
Abuja 18
Columbus 18
Turku 17
Brooklyn 16
Chennai 16
Tianjin 15
Warsaw 15
Brussels 14
Guangzhou 14
Montreal 14
Haiphong 13
Paris 13
San Francisco 13
Manchester 12
Mexico City 12
Nuremberg 12
Vienna 12
Amsterdam 11
Bari 11
Hebei 11
Palermo 11
Piscataway 11
Abidjan 10
Bologna 10
Cardiff 10
Dong Ket 10
Kunming 10
L’Aquila 10
Norwalk 10
Redwood City 10
Rio de Janeiro 10
Brescia 9
Denver 9
Lappeenranta 9
Mogliano 9
Mumbai 9
Philadelphia 9
Toronto 9
Washington 9
Zhengzhou 9
Candiolo 8
Falkenstein 8
Totale 9.550
Nome #
Ligandi TRPV1 496
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 401
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 359
Cytotoxic effects of cannabinoids on human HT-29 colorectal adenocarcinoma cells: different mechanisms of THC, CBD, and CB83 359
Synthesis of pyrazolo[1,5-a]pyrimidine ring as a possible bioisosteric replacement of the 5-(1H-pyrrol-1-yl)pyrazole scaffold 355
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 307
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors 298
Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators 295
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains 275
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 270
Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening 262
Anti-Inflammatory and Antinociceptive Properties of the Quercetin-3-Oleate AV2, a Novel FFAR1 Partial Agonist 254
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 254
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 251
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 245
Screen of unfocused libraries identified compounds with direct or synergistic antibacterial activity 245
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 244
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 239
Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol 237
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoids Receptors 233
Design, synthesis, and physicochemical and pharmacological profiling of 7‐Hydroxy-5-oxopyrazolo[4,3‐b]pyridine-6-carboxamide derivatives with antiosteoarthritic activity in vivo 232
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 231
A multitarget semi-synthetic derivative of the flavonoid morin with improved in vitro vasorelaxant activity: Role of CaV1.2 and KCa1.1 channels 230
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 228
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 226
Active manganese dioxide promoted cyclization of ortho-(1H-pyrrol-1-yl)aryl and heteroaryl carboxylic acids to 5H-pyrrolo[1,2-a][3,1]benzoxazin-5-one derivatives 223
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides 221
Nuovi Potenti e Selettivi ligandi dei recettori dei cannabinoidi 220
3-Amino-alkylated indoles: Unexplored green products acting as anti-inflammatory agents 220
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 214
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors 213
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 213
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides 212
Design, synthesis and pharmacological evaluation of ester-based quercetin derivatives as selective vascular KCa1.1 channel stimulators 212
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 208
Conformational Analysis of the N-Arachinylethanolamide (Anandamide) using Nuclear Magnetic Resonance and Theoretical Calculations 205
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 204
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 204
Anti-addictive properties of COR659 – Additional pharmacological evidence and comparison with a series of novel analogues 202
TRPV1-FAAH-COX: The Couples Game in Pain Treatment 200
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 198
Computational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors 194
HIV-Reverse Transcriptase Inhibition: Inclusion of Ligand-Induced Fit by Cross-Docking Studies 191
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 189
Thiazolothiazepine Inhibitors of HIV-1 Integrase 187
Pinocembrin and its linolenoyl ester derivative induce wound healing activity in HaCaT cell line potentially involving a GPR120/FFA4 mediated pathway 186
Identification and Quantification of Trans-Resveratrol in Dietary Supplements by a Rapid and Straightforward RP-HPLC Method 175
Design, synthesis and in vitro experimental validation of novel TRPV4 antagonists inspired by labdane diterpenes 171
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile 170
Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii 167
Polycondensed Heterocycles. Part 11: Preparation and Regioselective Reductions of 5-Phenyl-4H-pyrrolo[1,2-a][1]benzazepin-4-one 163
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 159
Suppressing effect of the novel positive allosteric modulator of the GABAB receptor, COR659, on locomotor hyperactivity induced by different drugs of abuse 159
An approach to the stereo-controlled synthesis of polycyclic derivatives of L-4-thiazolidinecarboxilic acid active against HIV-1 integrase 158
Synthesis of some novel 1-aryl-1H-1,2,3-triazole-4-carboxamides and ethyl 1-aryl-5-(1,2,3-triazol-1-yl)-1H-pyrazole-4-carboxylates 147
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo 146
Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists 143
Napthoxazepine Inhibitors of HIV-1 Integrase: Synthesis and Biological Evaluation 143
New synthesis of N1- and N2-substituted pyrazolo[4,3-b]pyridine-5-one derivatives as CB2 receptor ligands 140
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands 129
Targeting neuropathic pain: pathobiology, current treatment and peptidomimetics as a new therapeutic opportunity 128
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor 124
GPR120/FFAR4 pharmacology: focus on agonists in Type 2 diabetes mellitus drug discovery 124
Development of 1-(2-aminophenyl)pyrrole-based amides acting as human topoisomerase I inhibitors 124
Old strategies and new perspectives in modulating the endocannabinoid system 117
The GABAB receptor positive allosteric modulator COR659: in vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives 113
Investigation on Novel E/Z 2-Benzylideneindan-1-One-Based Photoswitches with AChE and MAO-B Dual Inhibitory Activity 112
Structure optimization of positive allosteric modulators of GABAB receptors led to the unexpected discovery of antagonists/potential negative allosteric modulators 100
Targeting TRPA1 with Novel Synthetic Compounds Based on Different Scaffolds to Reduce Acute and Chronic Pain 5
Light-Controlled Modulation of the Endocannabinoid System: Photoswitchable Ligands for Cannabinoid and TRPV1 Receptors 4
Totale 14.463
Categoria #
all - tutte 43.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 0 0 0 0 0 0 73
2021/20221.054 84 121 97 102 64 41 50 55 45 113 96 186
2022/20231.150 81 88 177 136 100 225 45 92 91 29 60 26
2023/20241.133 58 24 92 63 63 236 363 36 17 40 28 113
2024/20252.156 59 98 230 127 247 145 98 134 178 114 207 519
2025/20264.886 390 779 575 586 876 192 581 165 169 261 164 148
Totale 14.463